FOLH1 and prostate cancer: In recent years, positron emission tomography (PET) imaging using prostate-specific membrane antigen (PSMA) radiotracers has emerged as a valuable diagnostic tool in detecting prostate cancer metastases, including those in rare locations such as the pituitary gland.